![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: POP1 |
Gene summary for POP1 |
![]() |
Gene information | Species | Human | Gene symbol | POP1 | Gene ID | 10940 |
Gene name | POP1 homolog, ribonuclease P/MRP subunit | |
Gene Alias | ANXD2 | |
Cytomap | 8q22.2 | |
Gene Type | protein-coding | GO ID | GO:0000966 | UniProtAcc | Q99575 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10940 | POP1 | P2T-E | Human | Esophagus | ESCC | 3.08e-12 | 1.79e-01 | 0.1177 |
10940 | POP1 | P4T-E | Human | Esophagus | ESCC | 3.09e-03 | 1.51e-01 | 0.1323 |
10940 | POP1 | P5T-E | Human | Esophagus | ESCC | 9.22e-10 | 2.04e-01 | 0.1327 |
10940 | POP1 | P8T-E | Human | Esophagus | ESCC | 2.47e-06 | 1.08e-01 | 0.0889 |
10940 | POP1 | P9T-E | Human | Esophagus | ESCC | 2.42e-05 | 1.10e-01 | 0.1131 |
10940 | POP1 | P10T-E | Human | Esophagus | ESCC | 2.86e-08 | 1.32e-01 | 0.116 |
10940 | POP1 | P11T-E | Human | Esophagus | ESCC | 4.81e-03 | 1.50e-01 | 0.1426 |
10940 | POP1 | P12T-E | Human | Esophagus | ESCC | 1.07e-03 | 1.01e-01 | 0.1122 |
10940 | POP1 | P16T-E | Human | Esophagus | ESCC | 3.48e-09 | 2.36e-01 | 0.1153 |
10940 | POP1 | P17T-E | Human | Esophagus | ESCC | 2.37e-09 | 2.72e-01 | 0.1278 |
10940 | POP1 | P20T-E | Human | Esophagus | ESCC | 8.56e-16 | 3.89e-01 | 0.1124 |
10940 | POP1 | P21T-E | Human | Esophagus | ESCC | 3.67e-15 | 3.03e-01 | 0.1617 |
10940 | POP1 | P22T-E | Human | Esophagus | ESCC | 5.04e-09 | 1.98e-01 | 0.1236 |
10940 | POP1 | P23T-E | Human | Esophagus | ESCC | 1.74e-04 | 1.73e-01 | 0.108 |
10940 | POP1 | P24T-E | Human | Esophagus | ESCC | 4.15e-07 | 8.37e-02 | 0.1287 |
10940 | POP1 | P26T-E | Human | Esophagus | ESCC | 2.19e-07 | 1.41e-01 | 0.1276 |
10940 | POP1 | P27T-E | Human | Esophagus | ESCC | 3.39e-18 | 1.60e-01 | 0.1055 |
10940 | POP1 | P28T-E | Human | Esophagus | ESCC | 6.81e-14 | 2.87e-01 | 0.1149 |
10940 | POP1 | P30T-E | Human | Esophagus | ESCC | 5.55e-08 | 3.56e-01 | 0.137 |
10940 | POP1 | P31T-E | Human | Esophagus | ESCC | 6.83e-24 | 4.72e-01 | 0.1251 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003447015 | Esophagus | ESCC | ncRNA processing | 300/8552 | 395/18723 | 3.09e-35 | 3.26e-32 | 300 |
GO:003466012 | Esophagus | ESCC | ncRNA metabolic process | 346/8552 | 485/18723 | 4.35e-31 | 2.51e-28 | 346 |
GO:0006401110 | Esophagus | ESCC | RNA catabolic process | 204/8552 | 278/18723 | 3.39e-21 | 5.66e-19 | 204 |
GO:0034655110 | Esophagus | ESCC | nucleobase-containing compound catabolic process | 272/8552 | 407/18723 | 2.92e-18 | 2.90e-16 | 272 |
GO:004670018 | Esophagus | ESCC | heterocycle catabolic process | 286/8552 | 445/18723 | 1.12e-15 | 7.47e-14 | 286 |
GO:004427019 | Esophagus | ESCC | cellular nitrogen compound catabolic process | 288/8552 | 451/18723 | 3.03e-15 | 1.79e-13 | 288 |
GO:001943918 | Esophagus | ESCC | aromatic compound catabolic process | 295/8552 | 467/18723 | 1.09e-14 | 5.98e-13 | 295 |
GO:190136118 | Esophagus | ESCC | organic cyclic compound catabolic process | 307/8552 | 495/18723 | 9.99e-14 | 4.80e-12 | 307 |
GO:00905013 | Esophagus | ESCC | RNA phosphodiester bond hydrolysis | 110/8552 | 152/18723 | 1.95e-11 | 6.81e-10 | 110 |
GO:00080333 | Esophagus | ESCC | tRNA processing | 92/8552 | 127/18723 | 7.83e-10 | 1.93e-08 | 92 |
GO:00063992 | Esophagus | ESCC | tRNA metabolic process | 122/8552 | 179/18723 | 9.03e-10 | 2.19e-08 | 122 |
GO:00903053 | Esophagus | ESCC | nucleic acid phosphodiester bond hydrolysis | 163/8552 | 261/18723 | 3.07e-08 | 5.73e-07 | 163 |
GO:00346613 | Esophagus | ESCC | ncRNA catabolic process | 33/8552 | 43/18723 | 3.25e-05 | 2.69e-04 | 33 |
GO:00905023 | Esophagus | ESCC | RNA phosphodiester bond hydrolysis, endonucleolytic | 55/8552 | 82/18723 | 7.34e-05 | 5.51e-04 | 55 |
GO:00344713 | Esophagus | ESCC | ncRNA 5'-end processing | 18/8552 | 21/18723 | 1.81e-04 | 1.16e-03 | 18 |
GO:00009663 | Esophagus | ESCC | RNA 5'-end processing | 19/8552 | 23/18723 | 3.12e-04 | 1.85e-03 | 19 |
GO:00991163 | Esophagus | ESCC | tRNA 5'-end processing | 14/8552 | 16/18723 | 6.78e-04 | 3.56e-03 | 14 |
GO:00016823 | Esophagus | ESCC | tRNA 5'-leader removal | 11/8552 | 13/18723 | 4.76e-03 | 1.85e-02 | 11 |
GO:00160782 | Esophagus | ESCC | tRNA catabolic process | 11/8552 | 13/18723 | 4.76e-03 | 1.85e-02 | 11 |
GO:00344709 | Oral cavity | OSCC | ncRNA processing | 263/7305 | 395/18723 | 4.38e-29 | 2.78e-26 | 263 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
POP1 | deletion | Frame_Shift_Del | novel | c.294delN | p.Lys100SerfsTer3 | p.K100Sfs*3 | Q99575 | protein_coding | TCGA-21-1070-01 | Lung | lung squamous cell carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | ||
POP1 | SNV | Missense_Mutation | novel | c.887N>T | p.Arg296Leu | p.R296L | Q99575 | protein_coding | deleterious(0) | possibly_damaging(0.86) | TCGA-CN-6010-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | PD |
POP1 | SNV | Missense_Mutation | novel | c.898N>C | p.Tyr300His | p.Y300H | Q99575 | protein_coding | deleterious(0) | probably_damaging(0.99) | TCGA-F7-A624-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
POP1 | SNV | Missense_Mutation | novel | c.773A>G | p.Lys258Arg | p.K258R | Q99575 | protein_coding | tolerated(0.11) | possibly_damaging(0.597) | TCGA-J4-A83N-01 | Prostate | prostate adenocarcinoma | Male | <65 | 7 | Chemotherapy | gemcitabine | SD |
POP1 | SNV | Missense_Mutation | c.233N>G | p.Lys78Arg | p.K78R | Q99575 | protein_coding | tolerated(0.36) | benign(0.003) | TCGA-BR-4357-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD | |
POP1 | SNV | Missense_Mutation | c.2305N>A | p.Ala769Thr | p.A769T | Q99575 | protein_coding | tolerated(0.37) | benign(0.036) | TCGA-BR-6852-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
POP1 | SNV | Missense_Mutation | c.2641G>A | p.Glu881Lys | p.E881K | Q99575 | protein_coding | deleterious(0.01) | possibly_damaging(0.516) | TCGA-BR-7197-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
POP1 | SNV | Missense_Mutation | c.2114G>A | p.Cys705Tyr | p.C705Y | Q99575 | protein_coding | tolerated(1) | benign(0.011) | TCGA-BR-8361-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
POP1 | SNV | Missense_Mutation | c.971N>A | p.Ser324Asn | p.S324N | Q99575 | protein_coding | tolerated(0.65) | benign(0.003) | TCGA-BR-8372-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | etoposide | CR | |
POP1 | SNV | Missense_Mutation | c.292N>C | p.Ile98Leu | p.I98L | Q99575 | protein_coding | tolerated(0.42) | benign(0.003) | TCGA-BR-8680-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | CR |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |